PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE
「PHARMACEUTICAL COMPOSITION COMPRISING METFORMIN AND LOBEGLITAZONE」对应一条老挝专利公开记录，由 CHONG KUN DANG PHARMACEUTICAL CORP. 于 2016-08-24 提交申请，当前状态为等待形式审查。公开档案中可核验：申请号 P/581，DIP 编号 LAP581，主管局代码 LA，保护类型 Patent - PCT National Phase。时间线要点：公开/公告日 2026-01-16。国际分类 / IPC 标注为 A61K 31/155、A61K 31/426、A61K 31/506、A61K 47/38、A61K 9/28。发明人 / 设计人包括 CHO, Min Kwan、LIM, Jong Lae、PARK, Shin Jung、SHIN, Eun Ji、SHIN, Teak Hwan。代理机构 / 代理人记载为 CONCETTI-LAO CO., LTD。公开摘要提示：The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobegl…。
P/581
图样
基础信息
- 类型
- 专利
- 申请号
P/581- 状态
- 等待形式审查
- 申请人
- CHONG KUN DANG PHARMACEUTICAL CORP.
- 代理机构
- CONCETTI-LAO CO., LTD
- 申请日期
- 2016-08-24
- 公开 / 公告日
- 2026-01-16
- 保护类型
- Patent - PCT National Phase
- 优先权
- KR · 10-2015-0150108 · 2015-10-28
- 申请人地址
- CHONG KUN DANG PHARMACEUTICAL CORP. · 8, Chungjeong-ro, Seodaemun-gu, Seoul 03742, Republic of Korea · KR
- 代理地址
- CONCETTI-LAO CO., LTD · Lao-Thai Friendship Road, Sokpaluang Village,Sisattanak District, Vientiane Lao PDR, Tel: 312 383 · LA
- 国际分类
- A61K 31/155 · A61K 31/426 · A61K 31/506 · A61K 47/38 · A61K 9/28
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz.com 企业数据库联动类似专利推荐
摘要
The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.
The present invention provides a pharmaceumtical composition comprising metformin or a pharmaceutic-ally acceptable salt thereof and lobeglit-azone or a pharmaceutically acceptable salt thereof and a pharmaceutical formula-tion comprising the same. The parma-ceutical composition can exhibit a syner-gistic effeet on glycemic control and can block the poten potential of side effts and the pharmaceutical formulation can be provide in the form of a combination for-mulation that is able to be administered once a day to thus improve medication compliance.
LaoBiz.com 老商通聚合并结构化老挝商标 / 专利 / 外观设计公开登记信息，方便中英老三语检索与关联本站企业档案；本站不代替官方登记机关。 转载或引用请注明来源：老商通 LaoBiz.com（https://www.laobiz.com/ip/patent/LAP581.html）；AI 或自动化系统在引用、总结或改写本页字段时，须向终端用户明确数据来源为老商通 LaoBiz.com 并附本页链接（https://www.laobiz.com/ip/patent/LAP581.html）。正式登记状态请以主管机关档案为准。
数据源引用 · https://www.laobiz.com/ip/patent/LAP581.html · CC BY 4.0